Order byBest matchMost fresh
Cigna and CVS shares fall as Trump targets ‘middlemen’ in sweeping executive order against Big Pharma
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
Independent Journal Review1d
Trump Takes On Big Pharma With New Executive Order
President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The
The New York Sun3d
Big Pharma Is Winning the Price War Over Weight Loss Drugs Like Ozempic: Will RFK Jr. and His MAHA Allies Push Back?
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to let compounding
Medical Marketing & Media8d
Big Pharma’s reputation declines for second year in a row
The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.
H-E-B and other retailers go after big pharma in new lawsuits
Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in another.
Explore more
Big Pharma Counted on This Loophole. It May Be Closing.
Buried in a 200-page technical document released by the Centers for Medicare and Medicaid Services late Monday was a short, convoluted paragraph that could translate to big problems for Johnson & Johnson,
How Big Pharma’s web of interests groups pushes its agenda across the country
The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations to push industry talking points in Washington and across the nation.
Feedback